Read + Share
Mehlman C, Swalduz A, Monnet I, Morin C, et al. COMPOSIT study: evaluating osimertinib combination with targeted therapies in
EGFR-mutated non-small cell lung cancer. Oncologist 2024 Dec 26:oyae312. doi: 10.1093.
PMID: 39724403
|
 |
|
Mehlman C, Swalduz A, Monnet I, Morin C, et al. COMPOSIT study: evaluating osimertinib combination with targeted therapies in
EGFR-mutated non-small cell lung cancer. Oncologist 2024 Dec 26:oyae312. doi: 10.1093.
PMID: 39724403
|
|
|
|